U.S. Senate · 118th Congress · S. 775
Increasing Transparency in Generic Drug Applications Act
A bill to provide for increased transparency in generic drug applications.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Margaret Wood HassanD-NH
- Introduced
- March 14, 2023, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (3)
2 Republicans, 1 Democrat. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Rand PaulR-KY
Signed on later
- Mike BraunR-INMarch 28, 2023
- John W. HickenlooperD-COApril 25, 2023